⌘K
EN
FR
Awards
Acquisition du traitement CAR-T Kymriah (tisagenlecleucel)
20047341
$22.5M
Buyer
Santé Québec Est-de-l’Île-de-Montréal – Universitaire
Supplier
Novartis Pharma Canada inc.
Value
$22.5M
Award date
Jan 30, 2025
Status
active
Source
SEAO
20047341
Related procurement
View full record
Acquisition du traitement CAR-T Kymriah (tisagenlecleucel) | Government award · CanPursue